Dr Rutilio Garcia, MD | |
25 Medical Park, Valley, AL 36854-3665 | |
(334) 756-2189 | |
(334) 756-2139 |
Full Name | Dr Rutilio Garcia |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Location | 25 Medical Park, Valley, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558380311 | NPI | - | NPPES |
17129 | Other | BLUE CROSS BLUE SHIELD AL | |
11564467 | Other | CAQH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 13322 (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Rutilio Garcia, MD 25 Medical Park, Valley, AL 36854-3665 Ph: (334) 756-2189 | Dr Rutilio Garcia, MD 25 Medical Park, Valley, AL 36854-3665 Ph: (334) 756-2189 |
News Archive
A procurement document posted on a federal website gives the newest Obamacare contractor until mid-March to build the back end of healthcare.gov, predicting dire consequences if the work is not completed on time. Other media outlets report exchange developments from Maryland, Massachusetts, Missouri, North Carolina, Oregon, Wisconsin, Georgia and Minnesota.
A new report, 'No Second Chances', developed by the Baker Heart and Diabetes Institute and sponsored by Bayer, will be launched at Parliament House today, revealing that prevention of secondary heart attacks and strokes is critical to combating Australia's number one killer - cardiovascular disease.
Injuries and deaths resulting from medical errors can have profound long-term consequences on patients and families. Seriously harmed patients and/or family members who have lost a loved one may describe feelings of neglect, isolation, fear, anger, and despair, among other emotions, many of which can be heightened by organizational silence and withholding of information.
China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today issued a statement to address concerns that have been raised with respect to financial reports filed with the State Administration for Industry and Commerce ("SAIC") and the United States Securities and Exchange Commission ("SEC").
Published today in the journal GigaScience is a new open source, cloud-based tool called IDseq that makes it possible to rapidly detect, identify, and track emerging pathogens such as SARS-CoV-2.
› Verified 8 days ago